81 related articles for article (PubMed ID: 1874294)
1. Use of the OM-11-906 monoclonal antibody for determining p62 c-myc expression by flow cytometry in relation to prognosis in colorectal cancer.
Rowley S; Carpenter R; Newbold KM; Gearty J; Keighley MR; Donovan IA; Neoptolemos JP
Eur J Surg Oncol; 1991 Aug; 17(4):370-8. PubMed ID: 1874294
[TBL] [Abstract][Full Text] [Related]
2. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
[TBL] [Abstract][Full Text] [Related]
3. Correlation between c-myc protein expression and phases of the cell cycle in human colorectal carcinomas.
Sato H; Tsuchiya A; Abe R
Fukushima J Med Sci; 1995 Dec; 41(2):111-23. PubMed ID: 8823991
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P
Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053
[TBL] [Abstract][Full Text] [Related]
5. Comparison of deoxyribonucleic acid ploidy and nuclear expressed p62 c-myc oncogene in the prognosis of colorectal cancer.
Rowley S; Newbold KM; Gearty J; Keighley MR; Donovan IA; Neoptolemos JP
World J Surg; 1990; 14(4):545-50; discussion 551. PubMed ID: 2200214
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of DNA ploidy patterns of colorectal adenocarcinoma.
Lin JK; Chang SC; Yang SH; Jiang JK; Chen WC; Lin TC
Hepatogastroenterology; 2003; 50(54):1927-32. PubMed ID: 14696434
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis in colorectal carcinoma occurring in patients aged 45 years and under: relationship to prognosis, mitosis, and immunohistochemical demonstration of p53, c-myc and bcl-2 protein products.
Langlois NE; Lamb J; Eremin O; Heys SD
J Pathol; 1997 Aug; 182(4):392-7. PubMed ID: 9306959
[TBL] [Abstract][Full Text] [Related]
8. Expression of c-myc proteins in breast cancer as related to established prognostic factors and survival.
Pietiläinen T; Lipponen P; Aaltomaa S; Eskelinen M; Kosma VM; Syrjänen K
Anticancer Res; 1995; 15(3):959-64. PubMed ID: 7645986
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the c-myc proto-oncogene in colorectal carcinoma is associated with a reduced mortality that is abrogated by point mutation of the p53 tumor suppressor gene.
Smith DR; Goh HS
Clin Cancer Res; 1996 Jun; 2(6):1049-53. PubMed ID: 9816266
[TBL] [Abstract][Full Text] [Related]
10. [DNA as a prognostic factor in colorectal cancer. A retrospective analysis of 34 patients].
Bianchi A; Mallofre C; Serrano A; Suñol J; Barja J; Ubach M
Rev Esp Enferm Dig; 1993 Aug; 84(2):100-4. PubMed ID: 8398367
[TBL] [Abstract][Full Text] [Related]
11. DNA ploidy, c-myc oncoprotein p62 and v-H-ras oncoprotein p21 in colorectal carcinoma.
Teranishi T; Matsumoto K; Ishijima N; Miura T; Suzuki H
Surg Today; 1993; 23(1):89-91. PubMed ID: 8461612
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of p53 expression and DNA ploidy pattern in colorectal cancer].
Nakamura T; Hishiki S; Baba S
Gan To Kagaku Ryoho; 1993 Apr; 20(6):780-3. PubMed ID: 8489286
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric analysis of DNA abnormalities in colorectal carcinomas.
Bocquillon PG; Daver A; Page M; Dalifard I; Chassevent A; Cellier P; Bertrand G; Larra F; George P; Chabrun B
Bull Cancer; 1989; 76(3):291-300. PubMed ID: 2736315
[TBL] [Abstract][Full Text] [Related]
14. Cytometric ploidy and proliferative activity in colorectal carcinoma.
Grigolato P; Berenzi A; Benetti A; Chirico E; Cadei M; Casella C; Salerni B; Lojacono L
Eur J Histochem; 1994; 38(2):163-70. PubMed ID: 7524813
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of DNA flow cytometry in stomach cancer: a 5-year prospective study.
Lee KH; Lee JS; Lee JH; Kim SW; Suh C; Kim WK; Kim SH; Min YI; Kim BS; Park KC; Lee MS; Sun HS
Br J Cancer; 1999 Apr; 79(11-12):1727-35. PubMed ID: 10206284
[TBL] [Abstract][Full Text] [Related]
16. Long term follow-up of c-myc, p53 and proliferation measurements in malignant melanoma.
Ross DA; Laing JH; Sanders R; Wilson GD
Eur J Surg Oncol; 2006 Feb; 32(1):80-4. PubMed ID: 16256294
[TBL] [Abstract][Full Text] [Related]
17. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance.
Kohler M; Janz I; Wintzer HO; Wagner E; Bauknecht T
Anticancer Res; 1989; 9(6):1537-47. PubMed ID: 2697181
[TBL] [Abstract][Full Text] [Related]
18. The clinical significance of c-myc oncogene expression in melanomas of the scalp.
Chana JS; Grover R; Wilson GD; Hudson DA; Forders M; Sanders R; Grobbelaar AO
Br J Plast Surg; 1998 Apr; 51(3):191-4. PubMed ID: 9664877
[TBL] [Abstract][Full Text] [Related]
19. Measurement of c-myc oncogene expression provides an accurate prognostic marker for acral lentiginous melanoma.
Grover R; Chana J; Grobbelaar AO; Hudson DA; Forder M; Wilson GD; Sanders R
Br J Plast Surg; 1999 Mar; 52(2):122-6. PubMed ID: 10434891
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric analysis of DNA ploidy and cell proliferation activity in colorectal carcinoma.
Mazzei T; Tonelli F; Mini E; Mazzoni P; Pesciullesi A; Valanzano R; Ficari F; Biondi C; Periti P
Anticancer Res; 1995; 15(5B):2247-53. PubMed ID: 8572632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
